This Note argues that the FDA should implement more robust safeguards to regulate fertility-tracking apps that meet the definition of Software Applications for Contraception (“SACs”), and should hold SACs to the same regulatory standards in place for certain other contraceptives, such as intrauterine devices (“IUDs”) and multiple-use female condoms (“MUFCs”).